browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
aa2a21c5-f51a-4983-97f9-a85970c000e1
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:18:44
Income (reported)
$50,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

THE MCMANUS GROUP

Consulting

Contact
NATE GASPAR
Phone
+1 434-989-7548
Address
zip:20001, city:Washington, state:DC, street:610 10th St. NW Suite 300
Client

FULCRUM THERAPEUTICS

Rare disease biopharma company

State
MA
Country
US
Effective date
2025-01-01
Issues lobbied + lobbyists (1)

HCR — Health Issues

Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932) Issues related to FDA Accelerated Approval Pathways

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.